# Robins, Edwin MD, PS – FDA Inspection, Sep 13, 2022

Source: https://www.keypedia.com/records/fda_inspections/robins-edwin-md-ps/bc1e8e8c-bac4-4ee0-bb02-c1faad77e8f6
Source feed: FDA_Inspections

> FDA inspection 1180602 of Robins, Edwin MD, PS, September 13, 2022. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1180602
- Company Name: Robins, Edwin MD, PS
- Inspection Date: 2022-09-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1273223 - 2025-06-13
- FDA Inspection 1006801 - 2017-04-12
- FDA Inspection 934244 - 2015-06-24
- [FDA Inspection 791248 - 2012-07-18](https://www.keypedia.com/records/fda_inspections/robins-edwin-md-ps/0756b8c9-e3b8-4fc5-a645-b5ca0a440bba)
- [FDA Inspection 660613 - 2010-04-08](https://www.keypedia.com/records/fda_inspections/robins-edwin-md-ps/c7015e6b-4e6f-458f-8f18-413d41959db3)

Company: https://www.keypedia.com/companies/robins-edwin-md-ps/fa688efb-6471-442e-b77a-a1f717b96490

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d